[Tumor necrosis factor or cachectin].
Marcheş
F
F
Institut de Virologie Stefan S. Nicolau, Bucarest, Roumanie.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002100:Cachexia / Q000503:physiopathology; D004247:DNA / Q000235:genetics; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D009369:Neoplasms / Q000628:therapy; D009374:Neoplasms, Experimental / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology; D012772:Shock, Septic / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000494:pharmacology* / Q000502:physiology / Q000627:therapeutic use
D000998:Antiviral Agents; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D004247:DNA
Le facteur de nécrose tumorale ou cachectine.